Dr. Talha Muhammed Qureshi, MD

Dr. Qureshi practices at Rockford Gastroenterology Associates in Rockford, Illinois.

Dr. Qureshi's NPI, 1871957183, was assigned on April 12, 2016. Dr. Qureshi graduated from Rush Medical College in 2016. Dr. Qureshi holds Illinois license 36158753.

Dr. Qureshi's primary practice is Rockford Gastroenterology Associates, at 401 Roxbury Rd, Rockford, IL 61107. The practice phone is (815) 397-7340.

Dr. Qureshi's primary practice is Rockford Gastroenterology Associates in Rockford, Illinois. Dr. Qureshi is also affiliated with UW Health SwedishAmerican Hospital. The medical group on file is Rockford Gastroenterology Associates. Dmand AI also links Dr. Qureshi to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Qureshi's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Qureshi practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Qureshi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Qureshi is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Qureshi's licenses on file in 3 states: Illinois, Texas and New York.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, gastrointestinal bleeding, intestinal diverticulosis and upper GI endoscopy among the conditions Dr. Qureshi treats.

CMS data shows 6,708 Medicare services from Dr. Qureshi across 18 procedure codes in 2024, for 415 Medicare patients. Medicare paid $160,855 for them.

CMS counts 415 Medicare patients who saw Dr. Qureshi in 2024. The largest group is 65 to 74, with 206 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Qureshi's median patient age at 62, with 55% women.

In 2024, Dr. Qureshi wrote 709 Medicare Part D claims for 204 patients. 78% of them were for generic drugs. CMS names the drug for 537 of them, across 13 drugs with 11 or more claims each, at $50,061 in total drug cost. In 2023, CMS named 665 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Qureshi for performance year 2024, reported as part of a group. Dr. Qureshi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 104 procedures of colonoscopy by Dr. Qureshi, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Qureshi, published from 2013 to 2021. 2019 was the busiest year, with 4. The most frequent topics are Endoscopy, Pituitary Neoplasms and Postoperative Complications. Dr. Qureshi has published most often in Cureus. Dr. Qureshi's most frequent co-authors are Richard W. Byrne, MD, Shiven Chaudhry, MD and Fahad M. Chaus, MBA, MD.

CMS Open Payments shows 69 general payments to Dr. Qureshi from 24 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $883.

Dmand AI lists 3 awards for Dr. Qureshi, most recently Lillie E Crain Research Scholarship in 2018.

Dr. Qureshi graduated from Rush Medical College in 2016. Dr. Qureshi is a member of ACP.

Dr. Qureshi is in network with 10 carriers, including Aetna, Elevance and HCSC. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.